BSCL2 Protein (Seipin)
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="text-align:center;">BSCL2 / Seipin</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Berardinelli-Seip Congenital Lipodystrophy 2 Protein (Seipin)</td></tr>
<tr><td><strong>Encoded by</strong></td><td>[BSCL2](/entities/bscl2)</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q96G97](https://www.uniprot.org/uniprotkb/Q96G97/entry)</td></tr>
<tr><td><strong>Localization</strong></td><td>Endoplasmic reticulum membrane</td></tr>
<tr><td><strong>Core Function</strong></td><td>Lipid droplet biogenesis and ER lipid homeostasis</td></tr>
<tr><td><strong>Neurologic Disease Link</strong></td><td>Seipinopathy spectrum (dHMN, Silver syndrome, SPG17)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
BSCL2 (seipin) is an ER membrane protein required for normal lipid droplet formation and lipid partitioning.[@sui2018][@arlt2022] Human disease data define two broad phenotypic classes: recessive loss-of-function states associated with congenital generalized lipodystrophy, and dominant missense seipinopathies (notably N88S/S90L) linked to motor-neuron-predominant neurodegeneration.[@windpassinger2004][@irobi2004]
Structure and Cell Biology
...BSCL2 Protein (Seipin)
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="text-align:center;">BSCL2 / Seipin</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Berardinelli-Seip Congenital Lipodystrophy 2 Protein (Seipin)</td></tr>
<tr><td><strong>Encoded by</strong></td><td>[BSCL2](/entities/bscl2)</td></tr>
<tr><td><strong>UniProt</strong></td><td>[Q96G97](https://www.uniprot.org/uniprotkb/Q96G97/entry)</td></tr>
<tr><td><strong>Localization</strong></td><td>Endoplasmic reticulum membrane</td></tr>
<tr><td><strong>Core Function</strong></td><td>Lipid droplet biogenesis and ER lipid homeostasis</td></tr>
<tr><td><strong>Neurologic Disease Link</strong></td><td>Seipinopathy spectrum (dHMN, Silver syndrome, SPG17)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
BSCL2 (seipin) is an ER membrane protein required for normal lipid droplet formation and lipid partitioning.[@sui2018][@arlt2022] Human disease data define two broad phenotypic classes: recessive loss-of-function states associated with congenital generalized lipodystrophy, and dominant missense seipinopathies (notably N88S/S90L) linked to motor-neuron-predominant neurodegeneration.[@windpassinger2004][@irobi2004]
Structure and Cell Biology
Cryo-EM work resolved seipin as an oligomeric ring-like assembly that organizes neutral lipid phase transitions at ER-lipid droplet nucleation sites.[@sui2018][@arlt2022] This architecture supports a scaffold-and-gate model:
- seipin marks permissive ER microdomains,
- concentrates lipid intermediates and partner proteins,
- and stabilizes early droplet growth to prevent aberrant tiny or supersized droplets.[@sui2018][@arlt2022]
Seipin dysfunction perturbs ER membrane organization, lipid droplet morphology, and stress signaling.
Physiologic Function in Nervous Tissue
Although classically framed in adipocyte biology, seipin has direct neurologic relevance:
- [neurons](/entities/neurons) rely on ER-lipid coupling for membrane maintenance and trafficking,
- axons are vulnerable to chronic ER stress and proteostasis failure,
- and lipid handling defects can amplify mitochondrial and inflammatory injury cascades.
Experimental models indicate that seipin dysfunction can alter neuronal excitability and synaptic stability, consistent with motor-system vulnerability in BSCL2-related neurologic disorders.[@ito2007][@guo2013]
Role in Neurodegeneration
Seipinopathy Spectrum
Dominant BSCL2 missense variants were first established in distal hereditary motor neuropathy and Silver syndrome, with broader phenotypic spread including SPG17-like presentations.[@windpassinger2004][@irobi2004]
Mechanistic themes include:
- mutant seipin misfolding and ER retention,
- [unfolded protein response](/entities/unfolded-protein-response) activation,
- chronic ER stress signaling,
- and progressive motor-neuron dysfunction.[@ito2007][@guo2013]
Proteinopathy Framing
Seipinopathy is often modeled as a conformational disease: specific missense variants introduce toxic gain-of-function stress rather than simple haploinsufficiency.[@ito2007][@ito2008]
Broader Neurodegeneration Relevance
Seipin biology intersects with pathways central to [ALS](/diseases/amyotrophic-lateral-sclerosis), [hereditary spastic paraplegia](/diseases/hereditary-spastic-paraplegia), [mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction-parkinsons), and [ER stress](/mechanisms/er-stress-neurodegeneration), making BSCL2 a useful mechanistic bridge protein.
Therapeutic Targeting
Current Clinical State
No approved disease-modifying therapy is specific for seipinopathy. Management remains supportive and phenotype-guided (neuromuscular rehabilitation, spasticity management, complication surveillance).
Mechanism-Based Directions
Potential strategies under study include:
- ER stress mitigation and proteostasis modulation,[@guo2013][@ito2008]
- mutation-aware gene therapy concepts,
- and pathway-level lipid-homeostasis correction.
An important translational constraint is mutation heterogeneity: interventions likely need genotype-specific logic (dominant toxic variants versus recessive loss-of-function contexts).
Research Priorities
- Clarify human CNS cell-type-specific BSCL2 expression and vulnerability windows.
- Define biomarkers that report ER stress plus lipid-droplet dysregulation in vivo.
- Build trial-ready natural-history cohorts for rare BSCL2 neurologic phenotypes.
See Also
- [BSCL2 Gene](/entities/bscl2)
- [Lipid Metabolism in Neurodegeneration](/mechanisms/lipid-metabolism-neurodegeneration)
- [ER Stress in Neurodegeneration](/mechanisms/er-stress-neurodegeneration)
- [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
- [Motor Neurons](/cell-types/spinal-cord-motoneurons)
Brain Atlas Resources
- [Allen Human Brain Atlas - BSCL2 Expression](https://human.brain-map.org/microarray/search/show?search_term=BSCL2)
- [Allen Cell Type Atlas - BSCL2](https://celltypes.brain-map.org/)
- [Allen Mouse Brain Atlas - BSCL2](https://mouse.brain-map.org/)
- [BrainSpan - BSCL2 Developmental Expression](https://www.brainspan.org/)
External Links
- [BSCL2 Gene - NCBI](https://www.ncbi.nlm.nih.gov/gene/6307)
- [BSCL2 Protein - UniProt](https://www.uniprot.org/uniprotkb/Q96G97)
- [OMIM: BSCL2](https://www.omim.org/entry/269400)
- [OMIM: Seipinopathy variants](https://www.omim.org/entry/600182)
References
[Sui X, et al, Cryo-electron microscopy structure of the lipid droplet-formation protein seipin (2018)](https://pubmed.ncbi.nlm.nih.gov/30327422/)
[Arlt H, et al, Seipin forms a flexible cage at lipid droplet formation sites (2022)](https://pubmed.ncbi.nlm.nih.gov/35210614/)
[Windpassinger C, et al, Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome (2004)](https://pubmed.ncbi.nlm.nih.gov/14981520/)
[Irobi J, et al, The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V (2004)](https://pubmed.ncbi.nlm.nih.gov/15242882/)
[Ito D, et al, Molecular pathogenesis of seipin/BSCL2-related motor neuron diseases (2007)](https://pubmed.ncbi.nlm.nih.gov/17387721/)
[Guo Y, et al, Alleviation of seipinopathy-related ER stress by triglyceride storage (2013)](https://pubmed.ncbi.nlm.nih.gov/23250914/)
[Ito D, et al, Seipinopathy: a novel endoplasmic reticulum stress-associated disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18790819/)